Neuropediatrics 2024; 55(01): 023-031
DOI: 10.1055/s-0043-1776286
Original Article

Effects of Neonatal Hypoxic-Ischemic Injury on Brain Sterol Synthesis and Metabolism

Amanda M. Dave
1   Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, United States
2   Department of Pediatrics, Children's Hospital and Medical Center, Omaha, Nebraska, United States
3   Child Health Research Institute, Omaha, Nebraska, United States
Ned A. Porter
4   Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States
Zeljka Korade
1   Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, United States
3   Child Health Research Institute, Omaha, Nebraska, United States
5   Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, United States
Eric S. Peeples
1   Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, United States
2   Department of Pediatrics, Children's Hospital and Medical Center, Omaha, Nebraska, United States
3   Child Health Research Institute, Omaha, Nebraska, United States
› Author Affiliations
Funding This study is supported by the Child Health Research Institute, University of Nebraska Medical Center.


Background Neonatal hypoxic-ischemic brain injury (HIBI) results from disruptions to blood supply and oxygen in the perinatal brain. The goal of this study was to measure brain sterol metabolites and plasma oxysterols after injury in a neonatal HIBI mouse model to assess for potential therapeutic targets in the brain biochemistry as well as potential circulating diagnostic biomarkers.

Methods Postnatal day 9 CD1-IGS mouse pups were randomized to HIBI induced by carotid artery ligation followed by 30 minutes at 8% oxygen or to sham surgery and normoxia. Brain tissue was collected for sterol analysis by liquid chromatography with tandem mass spectrometry (LC–MS/MS). Plasma was collected for oxysterol analysis by LC–MS/MS.

Results There were minimal changes in brain sterol concentrations in the first 72 hours after HIBI. In severely injured brains, there was a significant increase in desmosterol, 7-DHC, 8-DHC, and cholesterol 24 hours after injury in the ipsilateral tissue. Lanosterol, 24-dehydrolathosterol, and 14-dehydrozymostenol decreased in plasma 24 hours after injury. Severe neonatal HIBI was associated with increased cholesterol and sterol precursors in the cortex at 24 hours after injury.

Conclusions Differences in plasma oxysterols were seen at 24 hours but were not present at 30 minutes after injury, suggesting that these sterol intermediates would be of little value as early diagnostic biomarkers.

Supplementary Material

Publication History

Received: 02 May 2023

Accepted: 18 September 2023

Article published online:
23 October 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

  • 1 Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010; 86 (06) 329-338
  • 2 Allen KA, Brandon DH. Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments. Newborn Infant Nurs Rev 2011; 11 (03) 125-133
  • 3 Schreglmann M, Ground A, Vollmer B, Johnson MJ. Systematic review: long-term cognitive and behavioural outcomes of neonatal hypoxic-ischaemic encephalopathy in children without cerebral palsy. Acta Paediatr 2020; 109 (01) 20-30
  • 4 Massaro AN, Wu YW, Bammler TK. et al. Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy. J Pediatr 2018; 194: 67-75.e1
  • 5 Rocha-Ferreira E, Kelen D, Faulkner S. et al. Systemic pro-inflammatory cytokine status following therapeutic hypothermia in a piglet hypoxia-ischemia model. J Neuroinflammation 2017; 14 (01) 44
  • 6 Graham EM, Everett AD, Delpech JC, Northington FJ. Blood biomarkers for evaluation of perinatal encephalopathy: state of the art. Curr Opin Pediatr 2018; 30 (02) 199-203
  • 7 Dave AM, Peeples ES. Cholesterol metabolism and brain injury in neonatal encephalopathy. Pediatr Res 2021; 90 (01) 37-44
  • 8 Yu Z, Li S, Lv SH. et al. Hypoxia-ischemia brain damage disrupts brain cholesterol homeostasis in neonatal rats. Neuropediatrics 2009; 40 (04) 179-185
  • 9 Nguyen AD, McDonald JG, Bruick RK, DeBose-Boyd RA. Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of insigs. J Biol Chem 2007; 282 (37) 27436-27446
  • 10 Jurevics HA, Kidwai FZ, Morell P. Sources of cholesterol during development of the rat fetus and fetal organs. J Lipid Res 1997; 38 (04) 723-733
  • 11 Porter FD. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 2008; 16 (05) 535-541
  • 12 Nägler K, Mauch DH, Pfrieger FW. Glia-derived signals induce synapse formation in neurones of the rat central nervous system. J Physiol 2001; 533 (Pt 3): 665-679
  • 13 Saher G, Stumpf SK. Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta 2015; 1851 (08) 1083-1094
  • 14 Lu F, Zhu J, Guo S. et al. Upregulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain. Pediatr Res 2018; 83 (06) 1218-1227
  • 15 Lu F, Fan S, Romo AR, Xu D, Ferriero DM, Jiang X. Serum 24S-hydroxycholesterol predicts long-term brain structural and functional outcomes after hypoxia-ischemia in neonatal mice. J Cereb Blood Flow Metab 2021; 41 (02) 312-323
  • 16 Millar LJ, Shi L, Hoerder-Suabedissen A, Molnár Z. Neonatal hypoxia ischaemia: mechanisms, models, and therapeutic challenges. Front Cell Neurosci 2017; 11: 78
  • 17 de Vries LS, Jongmans MJ. Long-term outcome after neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 2010; 95 (03) F220-F224
  • 18 Hassell KJ, Ezzati M, Alonso-Alconada D, Hausenloy DJ, Robertson NJ. New horizons for newborn brain protection: enhancing endogenous neuroprotection. Arch Dis Child Fetal Neonatal Ed 2015; 100 (06) F541-F552
  • 19 Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 2006; 28 (03) 178-182
  • 20 Leifsdottir K, Mehmet H, Eksborg S, Herlenius E. Fas-ligand and interleukin-6 in the cerebrospinal fluid are early predictors of hypoxic-ischemic encephalopathy and long-term outcomes after birth asphyxia in term infants. J Neuroinflammation 2018; 15 (01) 223
  • 21 Orrock JE, Panchapakesan K, Vezina G. et al. Association of brain injury and neonatal cytokine response during therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy. Pediatr Res 2016; 79 (05) 742-747
  • 22 Liu W, Xu L, Lamberson C, Haas D, Korade Z, Porter NA. A highly sensitive method for analysis of 7-dehydrocholesterol for the study of Smith-Lemli-Opitz syndrome. J Lipid Res 2014; 55 (02) 329-337
  • 23 Tallman KA, Allen LB, Klingelsmith KB. et al. Prescription medications alter neuronal and glial cholesterol synthesis. ACS Chem Neurosci 2021; 12 (04) 735-745
  • 24 Vannucci RC, Christensen MA, Yager JY. Nature, time-course, and extent of cerebral edema in perinatal hypoxic-ischemic brain damage. Pediatr Neurol 1993; 9 (01) 29-34
  • 25 Svoboda MD, Christie JM, Eroglu Y, Freeman KA, Steiner RD. Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders. Am J Med Genet C Semin Med Genet 2012; 160C (04) 285-294
  • 26 Zerenturk EJ, Sharpe LJ, Ikonen E, Brown AJ. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis. Prog Lipid Res 2013; 52 (04) 666-680
  • 27 Spann NJ, Garmire LX, McDonald JG. et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 2012; 151 (01) 138-152
  • 28 Yang X, Liao KH, Deng IB, Zhang LC. Knockdown of interleukin-6 plays a neuroprotective role against hypoxia-ischemia in neonatal rats via inhibition of caspase 3 and Bcl-2-associated X protein signaling pathway. Ibrain 2022; 8 (03) 413-428
  • 29 Xu L, Porter NA. Reactivities and products of free radical oxidation of cholestadienols. J Am Chem Soc 2014; 136 (14) 5443-5450
  • 30 Korade Z, Xu L, Mirnics K, Porter NA. Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome. J Inherit Metab Dis 2013; 36 (01) 113-122
  • 31 Yamada N, Karasawa T, Komada T. et al. DHCR7 as a novel regulator of ferroptosis in hepatocytes [Internet]. bioRxiv 2022 p. 2022.06.15.496212. Accessed January 18, 2023 at:
  • 32 McAdams RM, Berube MW. Emerging therapies and management for neonatal encephalopathy-controversies and current approaches. J Perinatol 2021; 41 (04) 661-674
  • 33 Nair J, Kumar VHS. Current and emerging therapies in the management of hypoxic ischemic encephalopathy in neonates. Children (Basel) 2018; 5 (07) 99
  • 34 Perrone S, Grassi F, Caporilli C. et al. Brain damage in preterm and full-term neonates: serum biomarkers for the early diagnosis and intervention. Antioxidants 2023; 12 (02) 309
  • 35 Björkhem I, Lütjohann D, Diczfalusy U, Ståhle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 1998; 39 (08) 1594-1600